🇺🇸 FDA
Pipeline program

TAK-875 and Glimepiride

TAK-875_118

Phase 1 small_molecule completed

Quick answer

TAK-875 and Glimepiride for Pharmacokinetics is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Pharmacokinetics
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials